Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFN-15 for Migraine with Allodynia
NCT03472378Phase 2Completed
- Sponsor
- Hartford Hospital
- Start
- May 2018
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib oral solution in migraine, allodynia, sponsored by Hartford Hospital. Started May 2018; status: completed.
02
Drugs
celecoxib oral solution
03
Conditions
migraineallodynia
Beyond the preview
Go deeper on NCT03472378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472378.